Helen K. Chew, M.D.

Clinical/Research Interests
Title:
Specialty:
Center/Program Affiliation:
Address:
4501 X St.
Sacramento, CA 95817
Phone:
Education:
San Antonio, Texas
M.D. 1991
Stanford University
Palo Alto, California
B.S. 1986
Internships:
San Antonio, Texas
1991
Residency:
San Antonio, Texas
1994
Internal Medicine
Fellowships:
San Antonio, Texas
1998
Hematology/Oncology & Molecular Medicine
Board Certifications:
American Board of Internal Medicine, 1995
Professional Memberships:
Fellow, American College of Physicians
Southwest Oncology Group
Honors and Awards:
Find a Cure Award, South Placer Breast Cancer Endowment, 2007
Joyce Raley Teel Award for outstanding dedication to the cause of breast cancer, 2006
Christine & Helen Landgraf Memorial Award, 2001
VA Career Development Award, 1998
Select Recent Publications:
Barkauskas, D.A, An, H.J., Kronewitter, S.R, de Leoz, M.L., Chew, H.K., de Vere White, RW., Leiserowitz, G.S., Miyamoto. S, Lebrilla, C.B. and Rocke, D.M. 2009. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data, Bioinformatics, 25(2):251-7.
Chew, H.K., Doroshow, J., Frankel, P., Margolin, K., Somlo, G., Lenz, H.-J., Gordon, M., Zhang, W., Yang, D., Russell, C., Spicer, D., Synold, T., Bayer, R, Hantel, A, Stiff, P., Tetef, M. L., Gandara, D.R. and Albain, K. 2009. Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer, Journal of Clinical Oncology, (27) 13: 2163-9.
Chew, H.K., Barlow, W.E., Albain, K., Lew, D., Gown, A, Hayes, D.F., Gralow, J., Hortabagyi, G.N. and Livingston, R 2008. A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338, Clinical Breast Cancer, 8:511-515.
Chew, H.K., Davies, AM., Wun, T., Harvey, D., Zhou, H. and White RH. 2008. The incidence of venous thromboembolism among patients with primary lung cancer. Journal of Thrombosis and Haemostasis, 6:601-608 (Epub 2008 January).
Jeng, Y.-M., Cai-Ng, S., Li. A, Furuta, S., Chew, H., Chen, P.-L., Lee, E.-Y.-H. and Lee, W.-H. 2007. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing radiation. Oncogene, 26:6160-6166 (Epub 2007 April).
Chew, H.K., Wun, T., Harvey, D., Zhou, H. and White RH. 2007. The Incidence of Venous Thromboembolism and its Impact on Survival in Breast Cancer Patients, Journal of Clinical Oncology, 1:70-76.
Kirmiz D., Li B., An H.J., Clowers B.H., Chew H.K., Lam K.S., Ferrige A., Alecio R., Borow. A Serum Glycomics Approach to Breast cancer biomarkers. Molecular and Cellular Proteomics, 6(1): 43-55, 2007.
Semrad T.J., O'Donnell R., Wun T., Chew H., Harvery D., Zhou H., and White R.H. Epidemiology of Venous Thromboembolism in 9,489 Patients with Malignant glioma. Journal of Neurosurgery, 106(4): 601-8, 2007.
Moore H.C.F, Green S.J., Gralow J.R., Bearman S.I., Lew D., Barlow W.E., Hudis C., Wolff A.C., Ingle J.N., Chew H.K. Elias A.D. Intensive Dose-Dense Compared with High-Dose Adjuvant Chemotherapy for High-risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623. Journal of Clinical Oncology, 25: 1-6, 2007.
Rodriguez A., Wun T., Chew H.K., Zhou H., Harvey D., and White R.H. Venous Thromboembolism in Ovarian Cancer. Gynecologic Oncology, 105: 784-790, 2007.

